SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is seeing heightened activity as market participants closely track falling U.S. bond yields and a weakening dollar, which are fueling bullish sentiment for precious metals. Community discussions are heavily centered on a potential technical breakout, with many investors debating whether to accumulate physical holdings as a hedge against long-term fiat currency devaluation.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is experiencing intense community focus and bullish momentum following positive Phase 2 clinical trial results for its drug candidate ABCL635, which exceeded efficacy and safety expectations. Investors are actively debating the company's transition from a discovery platform to a proprietary drug developer, with many viewing this de-risked asset as a potential validator for the company's broader AI-driven platform.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is capturing significant market attention following its acquisition of three Boeing subsidiariesWisk Aero, SkyGrid, and Insituwhich has brought in an established defense revenue stream and solidified Boeing as a major shareholder. Investors and community members are closely monitoring upcoming earnings and integration progress, while traders debate the stock's potential for a short squeeze against its high short interest.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing high volatility as investors position themselves ahead of the upcoming earnings release, with heavy community focus on Neutron launch timelines and potential growth in space systems contracts. While some investors remain cautious about pre-earnings price fluctuations and potential short-term pullbacks, the broader conversation centers on long-term conviction in the companys vertically integrated infrastructure and its expanding role in the space economy.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is trending following a massive post-earnings rally driven by record demand for indium phosphide substrates, a critical material used in AI optical connectivity. While the company is seeing strong institutional support and analyst upgrades, the community remains divided, with some investors betting on a continued squeeze toward higher price targets, while others express caution regarding the sustainability of the valuation and potential risks tied to China-based manufacturing.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the upcoming earnings report and the company's strategic pivot into AI infrastructure, fueled by its recent Northern Data acquisition, 22,000 GPU capacity, and high short interest that has sparked intense community discussion about a potential short squeeze. Traders are keenly awaiting formal financial guidance and updates on major cloud contracts, which many believe will act as a re-rating catalyst for the stock's valuation.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors monitor the company's critical role in the U.S. defense supply chain and its ongoing government contract discussions. The community is actively debating the stock's potential for a short squeeze amidst significant institutional buying and expectations for a strong rebound in critical mineral demand.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing extreme volatility and intense community debate as investors weigh strong record revenue and security growth against post-earnings sell-offs and management's guidance. While many traders are focused on the stock's potential for an AI-driven rebound and short-squeeze setups, others are wary of the aggressive insider selling and the company's struggle to maintain momentum after recent earnings reports.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as institutional ownership by major firms continues to surge, fueling community speculation about an imminent buyout or positive data readout from the REGAL trial. Investors are closely monitoring the upcoming 80th trial event, with many actively discussing the potential for a market-moving catalyst as the company approaches its next earnings report.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) is under intense focus as investors weigh the impact of an emerging peace agreement between the U.S. and Iran, which has triggered volatility in crude oil markets and raised questions about the sustainability of current energy sector valuations. The community is actively debating the potential for a long-term supply shift, with some traders highlighting the critical nature of ongoing geopolitical tensions and low global inventories, while others speculate that the normalization of shipping traffic through the Strait of Hormuz could pressure oil-linked equities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates

BioLife Solutions (BLFS) delivered earnings and revenue surprises of +500.00% and +1.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Q2 Earnings and Revenues Surpass Estimates

Envista (NVST) delivered earnings and revenue surprises of +24.24% and +2.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Are Options Traders Betting on a Big Move in Agilent Technologies Stock?

Investors need to pay close attention to A stock based on the movements in the options market lately.

Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?

Kestra Medical Technologies, Ltd. (KMTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak implants, while Wellspect growth offers support.

Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?

COR's Q3 results could reflect specialty pharma strength, oncology expansion and margin gains, even as pricing dynamics and GLP-1 trends pressure revenues.

Solventum to Report Q2 Earnings: What's in Store for the Stock?

SOLV's Q2 results are likely to benefit from segment strength, Acera gains and cost savings, offset by tariffs and ERP-related sales timing shifts.

Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results

TMO lifted its 2026 outlook after Q2 topped estimates, driven by stronger demand, acquisitions and margin gains. Can the momentum continue?

How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends

TMO is expanding bioproduction, AI tools and clinical data capabilities, but execution will be key as competition intensifies.

Stryker (SYK) Q2 Earnings and Revenues Beat Estimates

Stryker (SYK) delivered earnings and revenue surprises of +6.65% and +0.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

$A Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.20 up 60.00% YoY
• Reported revenue of $1.83B up 10.01% YoY
• Agilent Technologies now expects fiscal year 2026 revenue between $7.39B and $7.49B, with non-GAAP EPS in the range of $6.00 to $6.10, an increase of 8 cents at the midpoint.

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Agilent Technologies Inc.

Agilent Wins TSA Contract To Upgrade US Airport Security Ahead Of FIFA World Cup 2026

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$1.49	--	--	N/A
Q2 '26	$1.41	$1.49	5.79%	BEAT
Q1 '26	$1.37	$1.36	-0.70%	MISSED
Q4 '25	$1.58	$1.59	0.36%	BEAT
Q3 '25	$1.37	$1.37	0.20%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '26

Historical Earnings